Related by context. Frequent words. (Click for all words.) 63 Eye Disease 62 Diabetic Retinopathy 58 neovascular AMD 58 placebo controlled clinical 57 diabetic retinopathy 56 lutein 56 substudy 56 phase IIa 55 subgroup analyzes 55 macular 55 NHANES 55 COPAXONE R 55 Phase 2a trial 55 cholinesterase inhibitors 55 lipid profiles 55 tocotrienols 54 diabetic macular edema DME 54 diabetic macular edema 54 Lutein 54 zeaxanthin 54 DASH diet 54 randomized clinical 54 placebo controlled studies 54 Macular Degeneration 54 microalbuminuria 54 randomized controlled clinical 54 Rosuvastatin 53 cognitively normal 53 Metabolic Syndrome 53 randomized controlled clinical trials 53 CATIE 53 antihypertensive medications 53 Dry Eye 53 donepezil 53 ranibizumab 53 Cardiovascular Risk 53 Phase 1b trial 53 drusen 53 calcium supplementation 53 cataract formation 53 teriparatide 52 Barrett Esophagus 52 ARVO 52 prospective observational 52 macular degeneration 52 NAFLD 52 Wilmer Eye Institute 52 montelukast 52 Phase III randomized 52 CYP#C# [001] 52 placebo controlled randomized 52 macular edema 52 prospective randomized controlled 52 ClinicalTrials.gov 52 candesartan 51 Phenoptin 51 Topiramate 51 C Reactive Protein 51 Diabetes Mellitus 51 Phase Ib 51 unblinded 51 randomized clinical trials 51 bosentan 51 nutritional supplementation 51 retrospective cohort study 51 retinopathy 51 multicenter randomized 51 Macugen 51 Molecular Cancer 51 Phase 2a clinical 51 Investigative Dermatology 51 randomized Phase III 51 Age Related Macular 51 phase IIb 51 antihypertensive drugs 51 prospective cohort 51 lipid lowering drugs 51 Phase Ia 51 visual acuity 50 related macular degeneration 50 Homocysteine 50 epicatechin 50 keratitis 50 Wet AMD 50 tipranavir 50 placebo controlled trials 50 Ginkgo biloba 50 liver fibrosis 50 vicriviroc 50 chromium picolinate 50 Phase IIa trial 50 RCTs 50 randomized trials 50 randomized placebo controlled 50 Parkinson disease PD 50 fasting blood glucose 50 attention-deficit/hyperactivity disorder ADHD 50 anti VEGF 50 dietary intake 50 active comparator 50 placebo controlled